Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative
- 8 December 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 165 (3) , 1375-1381
- https://doi.org/10.1016/0006-291x(89)92756-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- New acquisitions in the development of anti-HIV agentsAntiviral Research, 1989
- Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.The Journal of Experimental Medicine, 1988
- Dextran Sulfate Suppression of Viruses in the HIV Family: Inhibition of Virion Binding to CD4 + CellsScience, 1988
- New selective antiviral agents active against the AIDS virusTrends in Pharmacological Sciences, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDSScience, 1984